# Attachement - Qualification Process for Drug Development Tools: Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/attachement-qualification-process-for-drug-development-tools-qualification-of-exacerbations-of-chronic-pulmonary-disease-tool-for-measurement-of-symptoms-of-acute-bacterial-exacerbation-of-chronic-bronchitis-in-patients-with-chronic-obstructive-pulmonary-disease/88815054-17fc-4e46-a5c1-be7b0bad1ea9

> FDA guidance document: Attachement - Qualification Process for Drug Development Tools: Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease. Issue date: January 10, 2014. Get complete insights and analysis.

---

## Details

- Title: Attachement - Qualification Process for Drug Development Tools: Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2014-01-10
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-1630">FDA-2013-D-1630</a>

## Related Documents

- [Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act](https://www.keypedia.com/guidances/guidance-document/reporting-drug-sample-information-under-section-6004-of-the-affordable-care-act/324bb7a2-737c-4021-a1b4-e156ceed5ab8)
- [Drug Interaction Information in Human Prescription Drug and Biological Product Labeling](https://www.keypedia.com/guidances/guidance-document/drug-interaction-information-in-human-prescription-drug-and-biological-product-labeling/8bdf2914-581b-4e86-8a13-dacb0ef306c0)
- [Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease, a Patient-Reported Outcome Instrument for the Measurement of Severity of Respiratory Symptoms in Stable Chronic Obstructive Pulmonary Disease: Qualification for Exploratory Use](https://www.keypedia.com/guidances/guidance-document/evaluating-respiratory-symptoms-in-chronic-obstructive-pulmonary-disease-a-patient-reported-outcome-instrument-for-the-measurement-of-severity-of-respiratory-symptoms-in-stable-chronic-obstructive-pulmonary-disease-qualification-for-exploratory-use/a00af674-c3a1-4cdf-b25f-1b529c175262)